RRAS and colorectal carcinoma: This study not only provides an insight into the cellular and molecular mechanisms involved in the post-surgical distant recurrence, but also reveals that R-Ras and Transgelin may serve as prognostic biomarkers of Stage III CRC in clinical practice.